Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
CStone Pharmaceuticals (2616 HK)
Watchlist
89
Analysis
Health Care
•
Hong Kong
CStone Pharmaceuticals operates as a biotechnology company. The Company develops immuno-oncology and molecularly targeted drugs to address unmet medical needs for cancer patients. CStone Pharmaceuticals serves customers worldwide.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
03 Jul 2024 17:00
Voluntary Announcement - Cstone And Hengrui Enter Into An Exclusive Promotion Agreement Of Ayvakit (Avapritinib Tablets) In Mainland China
Attachment
Exchange Announcement •
18 Jun 2024 22:32
Change Of Joint Company Secretary, Process Agent And Authorized Representative And Waiver From Strict Compliance With Rules 3.28 And 8.17 Of The Listing Rules
Attachment
Exchange Announcement •
18 Jun 2024 21:50
Sixth Amended And Restated Memorandum And Articles Of Association
Attachment
Exchange Announcement •
18 Jun 2024 21:42
Poll Results Of Annual General Meeting Held On June 18, 2024 And Amendments To The Articles Of Association
Attachment
Exchange Announcement •
13 Jun 2024 12:00
Voluntary Announcement - Cstone Announces Approval Of Manufacturing Localization Registration Application For Ayvakit (Avapritinib Tablets) By China Nmpa
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x